We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$112B
AUM Growth
+$1.24B
Cap. Flow
-$4.67B
Cap. Flow %
-4.16%
Top 10 Hldgs %
33.05%
Holding
7,587
New
332
Increased
2,155
Reduced
4,171
Closed
298

Sector Composition

Rank Sector Weight
1 Financials 4.53%
2 Energy 3.9%
3 Technology 3.29%
4 Healthcare 2.41%
5 Industrials 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCLI
6851
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$2K ﹤0.01%
25
CIO
6852
DELISTED
City Office REIT
CIO
$2K ﹤0.01%
136
-21,620
-99% -$272K
CLMT icon
6853
PUT
Calumet Specialty Products
CLMT
$3.6B
$2K ﹤0.01%
500
CLPR
6854
Clipper Realty
CLPR
$46.4M
$2K ﹤0.01%
+160
New +$2.17K
CRSP icon
6855
CRISPR Therapeutics
CRSP
$4.6B
$2K ﹤0.01%
+100
New +$1.96K
DWSN icon
6856
Dawson Geophysical
DWSN
$149M
$2K ﹤0.01%
438
-19,583
-98% -$135K
EAD
6857
Allspring Income Opportunities Fund
EAD
$372M
$2K ﹤0.01%
310
+36
+13% +$305
FOCL
6858
EDAP TMS S.A.
FOCL
$231M
$2K ﹤0.01%
+600
New +$1.81K
FLGT icon
6859
Fulgent Genetics
FLGT
$556M
$2K ﹤0.01%
171
-22,709
-99% -$268K
FTEK icon
6860
Fuel Tech
FTEK
$47.4M
$2K ﹤0.01%
2,004
GLP icon
6861
PUT
Global Partners
GLP
$1.64B
$2K ﹤0.01%
+100
New +$1.98K
GORO icon
6862
PUT
Goldgroup Mining Inc.
GORO
$162M
$2K ﹤0.01%
500
GREK
6863
Global X MSCI Greece ETF
GREK
$292M
$2K ﹤0.01%
67
-224,006
-100% -$5.27M
HQH
6864
abrdn Healthcare Investors
HQH
$1.24B
$2K ﹤0.01%
81
-96,221
-100% -$2.26M
HST icon
6865
PUT
Host Hotels & Resorts
HST
$17.1B
$2K ﹤0.01%
100
-11,400
-99% -$208K
IESC icon
6866
IES Holdings
IESC
$12B
$2K ﹤0.01%
100
-7,786
-99% -$150K
INSG icon
6867
Inseego
INSG
$114M
$2K ﹤0.01%
110
IPG
6868
PUT
DELISTED
Interpublic Group of Companies
IPG
$2K ﹤0.01%
100
-100
-50% -$2.4K
LYTS icon
6869
LSI Industries
LYTS
$854M
$2K ﹤0.01%
230
-30,637
-99% -$297K
MPX
6870
DELISTED
Marine Products Corp
MPX
$2K ﹤0.01%
181
-7,437
-98% -$85.8K
OCGN icon
6871
Ocugen
OCGN
$427M
$2K ﹤0.01%
22
+9
+69% +$908
OPCH icon
6872
Option Care Health
OPCH
$3.42B
$2K ﹤0.01%
259
-28,036
-99% -$185K
PCYO icon
6873
Pure Cycle
PCYO
$260M
$2K ﹤0.01%
328
PGP
6874
PIMCO Global StockPLUS & Income Fund
PGP
$96.8M
$2K ﹤0.01%
90
PTCT icon
6875
PUT
PTC Therapeutics
PTCT
$6.29B
$2K ﹤0.01%
200
-34,400
-99% -$416K

Similar funds

Citigroup's Q1 2017 Portfolio in Review

As of Q1 2017, Citigroup held 7,587 positions worth $112B, up 1.1% from $111B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Citigroup withdrew a net $4.67B in Q1 2017, closing 298 positions and reducing 4,171 holdings. Its most notable exit was St Jude Medical, an estimated $368M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.5% of assets, down from 5% a quarter earlier, followed by Energy and Technology.

Against the trend, Citigroup opened a new position in Kayne Anderson Acquisition Corp. Unit worth $25.1M.

  • Citigroup's largest Q1 2017 buy was Kayne Anderson Acquisition Corp. Unit: 2,500,000 shares worth $25.1M.
  • Citigroup added most to Walt Disney in Q1 2017, an estimated $358M increase.
  • Citigroup's biggest Q1 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $1.61B.
  • Citigroup fully exited St Jude Medical in Q1 2017, selling an estimated $368M.
  • Citigroup's ten largest holdings make up 33% of its $112B portfolio in Q1 2017.
  • Citigroup opened 332 new positions and closed 298 in Q1 2017.
  • Citigroup's portfolio value rose 1.1% quarter-over-quarter to $112B.

Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.